Waddell & Reed Financial’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-44,450
Closed -$2.54M 605
2016
Q4
$2.54M Hold
44,450
0.01% 538
2016
Q3
$5.69M Buy
44,450
+3,270
+8% +$418K 0.01% 499
2016
Q2
$5.13M Buy
41,180
+1,250
+3% +$144K 0.01% 469
2016
Q1
$3.34M Hold
39,930
0.01% 530
2015
Q4
$3.95M Sell
39,930
-70,555
-64% -$7.56M 0.01% 517
2015
Q3
$13.5M Buy
110,485
+68,307
+162% +$9.27M 0.02% 367
2015
Q2
$6.47M Hold
42,178
0.01% 482
2015
Q1
$7.2M Hold
42,178
0.01% 468
2014
Q4
$6.45M Sell
42,178
-14,040
-25% -$1.75M 0.01% 468
2014
Q3
$5.96M Sell
56,218
-36,142
-39% -$5.04M 0.01% 472
2014
Q2
$14M Hold
92,360
0.02% 385
2014
Q1
$11.9M Sell
92,360
-15,160
-14% -$2.36M 0.02% 400
2013
Q4
$18.8M Hold
107,520
0.03% 337
2013
Q3
$17.3M Buy
107,520
+8,300
+8% +$1.31M 0.03% 335
2013
Q2
$13.2M Buy
+99,220
New +$14M 0.03% 344

Other funds holding ELGX

Waddell & Reed Financial's ELGX Position: Q1 2017 in Review

Waddell & Reed Financial sold out of Endologix Inc (ELGX) in Q1 2017, closing a stake of 44,450 shares — an estimated $2.54M sold.

Waddell & Reed Financial first reported a position in ELGX in Q2 2013 and held it in 15 quarters. The position peaked at $18.8M in Q4 2013. 129 funds tracked by Wall St. Rank hold ELGX as of Q1 2017.

  • Waddell & Reed Financial reported no remaining Endologix Inc position as of Q1 2017 after selling out during the quarter.
  • Waddell & Reed Financial sold 44,450 Endologix Inc shares in Q1 2017, an estimated $2.54M.
  • Waddell & Reed Financial first reported a position in Endologix Inc in Q2 2013 and held it in 15 quarters.
  • Waddell & Reed Financial's Endologix Inc position peaked at $18.8M in Q4 2013.
  • 129 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2017.

Based on Waddell & Reed Financial's 13F filing for Q1 2017, filed 15 May 2017.